• HSBC

1st CME program for pharmacist in the UAE concludes

  • United Arab Emirates: Thursday, October 23 - 2008 at 09:38
  • PRESS RELEASE

Over 220 pharmacists in Dubai and Abu Dhabi completed the first CME pharmacists program aimed at further educating pharmacists in the UAE.

The last two sessions of the 'Ask & Consult' program took place recently at the Sofitel Hotel Dubai and Sheraton Creek Abu Dhabi. The program was organized by Sanofi-aventis pharmaceuticals in association with Queen Margaret Medical School & University, United Kingdom, and accredited by the UAE Ministry of Health.

"Pharmacists are the gatekeepers of the community's wellbeing; they are the first point of contact for the patient."


said Alaa Al Naboulsy, Pharmacist, AlfaMed Group.

"I'm very glad these CME sessions are now available, we need to constantly build our existing knowledge base and we need to be updated on the latest treatment options in order to refer our patients/customers accurately."

The "Ask & Consult network" began in early 2008; it is an educational program for pharmacists to increase and up-date their medical knowledge. Six Sessions took place throughout the year (three in Dubai & three in Abu-Dhabi). The program was jointly developed with the full support of the Medical Collage of Queen Margaret University, headed and supervised by Prof. Douglas McBean
, Senior Lecturer, Physiology & Neurosciences, Queen Margaret University in Edinburgh since 1997. Pharmacists gained 12 CME hour credits by the UAE Ministry of Health, and a certificate of Program completion by Queen Margaret Medical School, and Queen Margaret University.

"We are very proud to be the pioneers for pharmacist education here in the UAE." said Mohammed Darwish, Senior Product Manager, Sanofi-aventis pharmaceuticals. "When we initially started, the program was called the 'Pharmacists Excellence Program', and was not CME accredited, but we changed it to 'Ask & Consult' a fully accredited CME program, after we witnessed tremendous attendance and genuine interest from pharmacists. This shows how eager this segment of healthcare professionals is to learn and be updated within their field."
Prof. Douglas McBean. 
Prof. Douglas McBean.
Article Options

Notes and Media Contacts »

About sanofi-aventis
Sanofi-aventis is one of the world's leading pharmaceutical companies. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris and in New York.

For more enquiries, please contact:
Dalia Aziz
Sanofi-aventis Pharmaceuticals
Office +971 4 4299202
Mobile +97150 6569940

Zeina El-Hakam
ASDA'A Burson Marsteller - Public Relations - Dubai
www.asdaa.com
T: +971 4 3355 969
M: +971 50 877 3400
F: +971 4 3356 080

Disclaimer »

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions